BLEEKER; Willem Karel

Patent Applications and Registrations

Patent applications and USPTO patent grants for BLEEKER; Willem Karel.The latest application filed is for "human antibodies against tissue factor and methods of use thereof".

Company Profile

3.11.17

BLEEKER; Willem Karel - Amsterdam NL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Human Antibodies Against Tissue Factor And Methods Of Use Thereof App 20210171657 - VERPLOEGEN; Sandra ; et al.	2021-06-10
Recombinant IgG4 monovalent antibodies Grant 10,351,629 - Schuurman , et al. July 16, 2	2019-07-16
Human Antibodies Against Tissue Factor and Methods of Use Thereof App 20190169311 - Verploegen; Sandra ; et al.	2019-06-06
Recombinant Monovalent Antibodies And Methods For Production Thereof App 20190169298 - PARREN; Paul ; et al.	2019-06-06
Recombinant monovalent antibodies and methods for production thereof Grant 10,155,816 - Parren , et al. Dec	2018-12-18
Human antibodies against tissue factor and methods of use thereof Grant 9,714,297 - Verploegen , et al. July 25, 2	2017-07-25
Human Antibodies And Antibody-drug Conjugates Against Cd74 App 20170173151 - VERPLOEGEN; Sandra ; et al.	2017-06-22
Transgenic Animals Producing Monovalent Human Antibodies And Antibodies Obtainable From These Animals App 20170037138 - SCHUURMAN; Janine ; et al.	2017-02-09
Methods and antibodies for treating cancer Grant 9,540,450 - Van De Winkel , et al. January 10, 2	2017-01-10
Human antibodies and antibody-drug conjugates against CD74 Grant 9,540,433 - Verploegen , et al. January 10, 2	2017-01-10
Recombinant IgG4 monovalent antibodies Grant 9,322,035 - Schuurman , et al. April 26, 2	2016-04-26
Human Antibodies Against Tissue Factor And Methods Of Use Thereof App 20160053020 - VERPLOEGEN; Sandra ; et al.	2016-02-25
Human antibodies against tissue factor and methods of use thereof Grant 9,150,658 - Verploegen , et al. October 6, 2	2015-10-06
Novel Methods And Antibodies For Treating Cancer App 20140348833 - VAN DE WINKEL; Jan ; et al.	2014-11-27
Human Antibodies And Antibody-drug Conjugates Against Cd74 App 20140030273 - Verploegen; Sandra ; et al.	2014-01-30
Human Antibodies Against Tissue Factor App 20110300156 - Verploegen; Sandra ; et al.	2011-12-08
Novel Methods And Antibodies For Treating Cancer App 20110256142 - Van De Winkel; Jan ; et al.	2011-10-20
Fusion Or Linked Proteins With Extended Half Life App 20110045007 - Schuurman; Janine ; et al.	2011-02-24
Non-glycosylated Recombinant Monovalent Antibodies App 20100325744 - Schuurman; Janine ; et al.	2010-12-23
Transgenic Animals Producing Monovalent Human Antibodies And Antibodies Obtainable From These Animals App 20100306867 - Schuurman; Janine ; et al.	2010-12-02
Method For Extending The Half-life Of Exogenous Or Endogenous Soluble Molecules App 20100291023 - Schuurman; Janine ; et al.	2010-11-18
Recombinant Fucose Modified Monovalent Half-antibodies Obtained By Molecular Engineering App 20100255012 - Schuurman; Janine ; et al.	2010-10-07
Recombinant Monovalent Antibodies And Methods For Production Thereof App 20090226421 - Parren; Paul ; et al.	2009-09-10

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.